NEW YORK (Reuters Health) – During the first year of treatment for chronic hepatitis B, tenofovir and entecavir are the most effective antiviral agents available, according to the…
NEW YORK (Reuters Health) – Patients with type 2 diabetes who have fairly high cholesterol levels despite simvastatin treatment do better with the addition of ezetimibe, Italian investigators…
NEW YORK (Reuters Health) – Patients infected with hepatitis C virus (HCV) type 1 who have a slow response to pegylated interferon-alfa and ribavirin can benefit from continuing…
Andre Machado, MD, Director, Center for Neurological Research, Cleveland Clinic, discusses deep brain stimulation, a technique that uses implantable pacemakers in the brain for treating neurological and psychiatric…
NEW YORK (Reuters Health) – In seeking the cause of hypoxemic acute respiratory failure (ARF) in hematology and oncology patients, broncho-alveolar lavage (BAL) adds little information to that…
NEW YORK (Reuters Health) – HIV-positive patients taking efavirenz are at risk for clinically significant vitamin D deficiency, and for excessive bone turnover if they are taking tenofovir,…
NEW YORK (Reuters Health) – Episodes of dyspnea are more common in patients treated with the antiplatelet agent than in those taking clopidogrel, although the clinical importance of…
NEW YORK (Reuters Health) – The risk of developing obesity-related cancer such as breast cancer or prostate cancer is apparently not curtailed in patients who undergo bariatric surgery…
NEW YORK (Reuters Health) – Independent of the usual markers of glycemic control, the amplitude of daily glucose excursions is associated with cognitive function in elderly patients with…
NEW YORK (Reuters Health) – Patients with chronic kidney disease not requiring hemodialysis present a dilemma when it comes to treating concomitant multivessel coronary artery disease (CAD): coronary…